Century Therapeutics, Inc.
NASDAQ:IPSCBiotechnology
Healthcare
$1.32 +0.48%
+$0.01 today
- Market cap
- $239.71M
- Beta
- 1.57
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$1.25
52W Low $0.44High $3.04
Volume 0.82M
Average 1.12M
Balance Sheet
Inspect the capital base behind the business.
Assets
$223.70M
FY 2025 · Annual
-36.7% YoYLiabilities
$64.77M
FY 2025 · Annual
-66.2% YoYEquity
$158.94M
FY 2025 · Annual
-1.5% YoYBalance Sheet
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 56.45M | 84.27M | 47.32M | 58.44M | 61.85M |
| Short-term Investments | 166.43M | 231.23M | 125.41M | 130.85M | 55.26M |
| Net Receivables | 250K | 780K | 665K | 1.52M | 667K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.79M | 462K | 1.79M | 860K | 2.99M |
| Total Current Assets | 228.15M | 319.72M | 176.99M | 194.05M | 120.77M |
| Property, Plant & Equipment (Net) | 69.82M | 111.73M | 92.08M | 90.85M | 66.17M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 34.2M | 34.2M |
| Long-term Investments | 135.91M | 51.85M | 91.08M | 30.82M | 2.36M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 3.49M | 3.24M | 541K | 3.3M | 211K |
| Total Non-current Assets | 209.22M | 166.82M | 183.7M | 159.17M | 102.94M |
| Total Assets | 437.38M | 486.54M | 360.69M | 353.22M | 223.7M |
| Account Payables | 7.6M | 5.45M | 2.74M | 3.08M | 4.77M |
| Short-term Debt | 1.04M | 6.5M | 1.51M | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 7.15M | 4.37M | 109.16M | 0 |
| Other Current Liabilities | 1.08M | 3.17M | 2.72M | 82K | 3.78M |
| Total Current Liabilities | 15.66M | 29.82M | 17.85M | 129.78M | 20.23M |
| Long-term Debt | 8.9M | 3.74M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 4.37M | 4.3M |
| Deferred Revenue (Non-current) | 0 | 110.83M | 111.38M | 0 | 0 |
| Other Non-current Liabilities | 2.02M | 718K | 56K | 8.74M | 0 |
| Total Non-current Liabilities | 25.48M | 153.99M | 158.1M | 62.07M | 44.54M |
| Total Liabilities | 41.14M | 183.81M | 175.94M | 191.85M | 64.77M |
| Common Stock | 5K | 6K | 6K | 9K | 9K |
| Retained Earnings | (388.17M) | (519.1M) | (655.77M) | (782.34M) | (791.92M) |
| Accumulated OCI | (650K) | (2.46M) | 108K | 324K | 30K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 396.24M | 302.74M | 184.75M | 161.36M | 158.94M |
| Total Debt | 25.12M | 49.41M | 48.17M | 53.83M | 43.57M |
| Net Debt | (31.33M) | (34.85M) | 847K | (4.61M) | (18.29M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $51.0M |
| Short-term Investments | $83.8M |
| Other Current | $4.2M |
| Total Current Assets | $139.0M |
| PP&E (Net) | $68.6M |
| Intangible Assets | $34.2M |
| Long-term Investments | $82.2M |
| Other Non-current | $2.6M |
| Total Non-current Assets | $187.5M |
| Total Assets | $326.6M |
Analysis
Selected assets total $326.6M for Latest. The largest visible component is Short-term Investments at $83.8M, about 25.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 8-K | Current report | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 5, 2026 | |
| 8-K | Current report | Oct 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 15, 2026 |
How much cash does IPSC have?
Century Therapeutics, Inc. (IPSC) reported $61.85M in cash and equivalents in fiscal 2025.
How much debt does IPSC carry?
Century Therapeutics, Inc. (IPSC) reported $43.56M of total debt, with net debt of -$18.29M.
Continue the stock analysis
Jump to another research area for this company.